https://orionbiotechnology.mydev.ca/conference-on-retroviruses-and-opportunistic-infection/ 2018-02-02T15:02:34+00:00 https://orionbiotechnology.mydev.ca/hiv-mucosal-immunology-meeting/ 2018-02-02T15:40:14+00:00 https://orionbiotechnology.mydev.ca/workshop-on-key-points-in-hiv-infection/ 2018-02-02T15:42:21+00:00 https://orionbiotechnology.mydev.ca/aids-2018/ 2018-02-02T15:53:30+00:00 https://orionbiotechnology.mydev.ca/non-human-primate-meeting/ 2018-02-02T16:14:01+00:00 https://orionbiotechnology.mydev.ca/orion-biotechnology-canada-announces-appointment-of-mark-groper-as-president-ceo/ 2018-03-28T02:25:34+00:00 https://orionbiotechnology.mydev.ca/orion-biotechnology-canada-appoints-new-chief-financial-officer/ 2018-05-01T13:00:37+00:00 https://orionbiotechnology.mydev.ca/researchers-at-queens-university-belfast-have-developed-a-vaginal-ring-capable-of-providing-sustained-delivery-of-ob-002-5p12-rantes-for-hiv-prevention/ 2019-02-12T20:36:49+00:00 https://orionbiotechnology.mydev.ca/orion-biotechnology-announces-receipt-of-pre-ind-guidance-from-the-united-states-fda-on-the-further-development-of-ob-002o-as-a-potential-treatment-for-solid-tumors/ 2019-06-10T21:11:52+00:00 https://orionbiotechnology.mydev.ca/orion-biotechnology-reports-additional-positive-preclinical-data-for-ob-002-in-the-treatment-of-colorectal-cancer/ 2019-06-20T18:32:53+00:00 https://orionbiotechnology.mydev.ca/orion-biotechnologys-ccr5-blocker-ob-002-shows-strong-efficacy-in-a-new-preclinical-model-of-multiple-sclerosis/ 2019-07-02T14:08:29+00:00 https://orionbiotechnology.mydev.ca/novel-drug-being-developed-for-cancer-indications-and-hiv-prevention-demonstrates-best-in-class-potency/ 2019-07-23T15:34:09+00:00 https://orionbiotechnology.mydev.ca/sir-gregory-winter-frs-to-chair-orion-biotechnologys-scientific-advisory-board/ 2019-08-06T17:45:34+00:00 https://orionbiotechnology.mydev.ca/the-national-centre-for-research-and-development-awards-orion-biotechnology-with-a-grant-to-progress-development-of-a-treatment-for-advanced-colorectal-cancer/ 2019-10-14T01:18:27+00:00 https://orionbiotechnology.mydev.ca/orion-biotechnology-to-announce-novel-potency-data/ 2019-10-14T01:19:16+00:00 https://orionbiotechnology.mydev.ca/orion-biotechnology-reports-positive-results-for-colorectal-cancer-in-preclinical-study/ 2019-10-14T01:20:28+00:00 https://orionbiotechnology.mydev.ca/industry-leader-joins-orion-biotechnology-board-of-directors/ 2019-10-14T01:20:54+00:00 https://orionbiotechnology.mydev.ca/1078-2/ 2019-10-14T01:21:18+00:00 https://orionbiotechnology.mydev.ca/orion-biotechnology-canada-announces-three-new-appointments-to-senior-management-team/ 2019-10-14T01:21:35+00:00 https://orionbiotechnology.mydev.ca/american-association-of-cancer-research-aacr-meeting/ 2019-10-14T01:22:01+00:00 https://orionbiotechnology.mydev.ca/bioequity-europe-2019/ 2019-10-14T01:22:17+00:00 https://orionbiotechnology.mydev.ca/5th-annual-immuno-oncology-bdl-and-investment-forum/ 2019-10-14T01:22:31+00:00 https://orionbiotechnology.mydev.ca/10th-ias-conference-on-hiv-science-ias-2019/ 2019-10-14T01:23:16+00:00 https://orionbiotechnology.mydev.ca/aids-2018-2/ 2019-10-14T01:23:45+00:00 https://orionbiotechnology.mydev.ca/orion-biotechnology-completes-scientific-advice-meeting-with-mhra/ 2019-10-14T01:24:10+00:00 https://orionbiotechnology.mydev.ca/orion-biotechnology-acquires-patent-portfolio-for-potent-ccr5-chemokine-antagonist/ 2019-10-14T01:24:49+00:00 https://orionbiotechnology.mydev.ca/orion-biotechnology-awarded-a-2m-grant-from-national-center-for-research-and-development-to-fund-further-development-of-its-hiv-microbicide-2/ 2019-10-14T01:25:09+00:00 https://orionbiotechnology.mydev.ca/orion-biotechnology-canada-acquires-k2biomedical-2/ 2019-10-14T01:25:31+00:00 https://orionbiotechnology.mydev.ca/orion-biotechnology-canada-announces-appointment-of-new-director-clinical-operations-2/ 2019-10-14T01:26:06+00:00 https://orionbiotechnology.mydev.ca/orion-biotechnology-canada-announces-partnership-with-nanjing-university-2/ 2019-10-14T01:26:34+00:00 https://orionbiotechnology.mydev.ca/orion-biotechnology-canada-announces-closing-of-5-million-financing/ 2019-10-14T01:27:12+00:00 https://orionbiotechnology.mydev.ca/orion-biotechnologys-chief-medical-officer-to-present-at-the-american-society-of-clinical-oncology-asco-meeting-in-chicago/ 2019-10-14T01:33:02+00:00 https://orionbiotechnology.mydev.ca/thomas-hecht-to-chair-orion-biotechnologys-board-of-directors/ 2019-11-14T04:22:03+00:00 https://orionbiotechnology.mydev.ca/ob-002-significantly-reduces-bone-metastasis-in-a-murine-model-of-breast-cancer/ 2019-11-14T04:22:33+00:00 https://orionbiotechnology.mydev.ca/american-society-of-clinical-oncology-asco-meeting/ 2019-11-18T18:50:48+00:00 https://orionbiotechnology.mydev.ca/bio-international-convention/ 2019-11-18T18:51:28+00:00 https://orionbiotechnology.mydev.ca/the-society-for-immunotherapy-of-cancers-sitc-34th-annual-meeting/ 2019-11-18T18:51:54+00:00 https://orionbiotechnology.mydev.ca/jefferies-2019-london-healthcare-conference/ 2019-11-18T20:08:49+00:00 https://orionbiotechnology.mydev.ca/wp-content/uploads/2019/11/conference-banner.jpg https://orionbiotechnology.mydev.ca/may-11-12th-bioequity-europe-2020/ 2020-03-05T18:21:50+00:00 https://orionbiotechnology.mydev.ca/wp-content/uploads/2020/03/Screenshot-2020-03-05-at-1.10.23-PM-1024x321.jpg https://orionbiotechnology.mydev.ca/may-29-april-2-asco-annual-meeting/ 2020-03-05T19:08:24+00:00 https://orionbiotechnology.mydev.ca/sept-18-sept-22-esmo-congress-2020/ 2020-03-05T20:26:49+00:00 https://orionbiotechnology.mydev.ca/wp-content/uploads/2020/03/Spain-Venue-300x208.jpg https://orionbiotechnology.mydev.ca/andreas-harstrick-joins-orion-biotechnologys-scientific-advisory-board/ 2020-03-06T02:21:26+00:00 https://orionbiotechnology.mydev.ca/orion-biotechnology-acquires-exclusive-license-to-university-of-geneva-novel-drug-discovery-platform/ 2020-03-06T06:43:26+00:00 https://orionbiotechnology.mydev.ca/bio-europe-spring-14th-annual-international-partnering-conference/ 2020-03-06T19:52:09+00:00 https://orionbiotechnology.mydev.ca/38th-annual-j-p-morgan-healthcare-conference/ 2020-03-06T19:53:21+00:00